دورية أكاديمية
أعرض في EDS

Recombinant TBEV Protein E of the Siberian Subtype Is a Candidate Antigen in the ELISA Test System for Differential Diagnosis.

التفاصيل البيبلوغرافية
العنوان: Recombinant TBEV Protein E of the Siberian Subtype Is a Candidate Antigen in the ELISA Test System for Differential Diagnosis.
المؤلفون: Baryshnikova V; FSASI 'Chumakov FSC R&D IBP RAS' (Institute of Poliomyelitis), Moscow 108819, Russia., Turchenko Y; FSASI 'Chumakov FSC R&D IBP RAS' (Institute of Poliomyelitis), Moscow 108819, Russia., Tuchynskaya K; FSASI 'Chumakov FSC R&D IBP RAS' (Institute of Poliomyelitis), Moscow 108819, Russia., Belyaletdinova I; FSASI 'Chumakov FSC R&D IBP RAS' (Institute of Poliomyelitis), Moscow 108819, Russia., Butenko A; D.I. Ivanovsky Institute of Virology Division of N.F. Gamaleya National Research Center of Epidemiology and Microbiology of the Ministry of Health of the Russian Federation, Moscow 123098, Russia., Dereventsova A; FSASI 'Chumakov FSC R&D IBP RAS' (Institute of Poliomyelitis), Moscow 108819, Russia., Ignatiev G; FSASI 'Chumakov FSC R&D IBP RAS' (Institute of Poliomyelitis), Moscow 108819, Russia., Kholodilov I; FSASI 'Chumakov FSC R&D IBP RAS' (Institute of Poliomyelitis), Moscow 108819, Russia., Larichev V; D.I. Ivanovsky Institute of Virology Division of N.F. Gamaleya National Research Center of Epidemiology and Microbiology of the Ministry of Health of the Russian Federation, Moscow 123098, Russia., Lyapeykova E; Infectious Clinical Hospital No. 1 of the Moscow City Health Department, Moscow 125310, Russia., Rogova A; FSASI 'Chumakov FSC R&D IBP RAS' (Institute of Poliomyelitis), Moscow 108819, Russia., Shakaryan A; FSASI 'Chumakov FSC R&D IBP RAS' (Institute of Poliomyelitis), Moscow 108819, Russia.; Department of Infectious Diseases in Children, Faculty of Pediatrics, Pirogov Russian National Research Medical University, Moscow 117997, Russia., Shishova A; FSASI 'Chumakov FSC R&D IBP RAS' (Institute of Poliomyelitis), Moscow 108819, Russia.; Institute of Translational Medicine and Biotechnology, Sechenov First Moscow State Medical University, Moscow 119991, Russia., Gmyl A; FSASI 'Chumakov FSC R&D IBP RAS' (Institute of Poliomyelitis), Moscow 108819, Russia., Karganova G; FSASI 'Chumakov FSC R&D IBP RAS' (Institute of Poliomyelitis), Moscow 108819, Russia.; Institute of Translational Medicine and Biotechnology, Sechenov First Moscow State Medical University, Moscow 119991, Russia.
المصدر: Diagnostics (Basel, Switzerland) [Diagnostics (Basel)] 2023 Oct 23; Vol. 13 (20). Date of Electronic Publication: 2023 Oct 23.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101658402 Publication Model: Electronic Cited Medium: Print ISSN: 2075-4418 (Print) Linking ISSN: 20754418 NLM ISO Abbreviation: Diagnostics (Basel) Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Basel, Switzerland : MDPI AG, [2011]-
مستخلص: The tick-borne encephalitis virus (TBEV) is one of the most common members of the Orthoflavivirus genus, which comprises the causative agents of severe diseases in humans and animals. Due to the expanding areas of orthoflavivirus infection, its differential diagnosis is highly demanded. Commercial test kits based on inactivated TBEV may not provide reliable differentiation between flaviviruses because of serological crossover in this genus. Application of recombinant domains (sE and dIII) of the TBEV Sukhar-strain protein E as antigens in an ELISA test system allowed us to identify a wide range of antibodies specific to different TBEV strains. We tested 53 sera from human patients with confirmed TBE diagnosis (the efficacy of our test system based on sE protein was 98%) and 56 sera from patients with other orthoflavivirus infections in which no positive ones were detected using our ELISA test system, thus being indicative of its 100% specificity. We also tested mouse and rabbit sera containing antibodies specific to 17 TBEV strains belonging to different subtypes; this assay exhibited high efficacy and differentiation ability in detecting antibodies against TBEV from other orthoflaviviruses such as Omsk hemorrhagic fever, Powassan, yellow fever, dengue, West Nile, Zika, and Japanese encephalitis viruses.
References: Mol Biol Evol. 2018 Jun 1;35(6):1547-1549. (PMID: 29722887)
Arch Virol. 2023 Jun 10;168(7):175. (PMID: 37296227)
J Clin Microbiol. 2004 Jun;42(6):2759-65. (PMID: 15184463)
Front Cell Infect Microbiol. 2022 Sep 15;12:975398. (PMID: 36189346)
Front Cell Infect Microbiol. 2020 Oct 22;10:572681. (PMID: 33194810)
PLoS Negl Trop Dis. 2019 Sep 20;13(9):e0007747. (PMID: 31539394)
Ticks Tick Borne Dis. 2016 Jul;7(5):723-729. (PMID: 26969490)
Diagnostics (Basel). 2020 May 14;10(5):. (PMID: 32423058)
Ticks Tick Borne Dis. 2016 Jul;7(5):979-982. (PMID: 27189583)
J Med Virol. 2019 Feb;91(2):190-200. (PMID: 30204244)
J Clin Microbiol. 2003 Sep;41(9):4336-42. (PMID: 12958266)
Biomed Res Int. 2015;2015:678084. (PMID: 26457301)
Diagnostics (Basel). 2023 Jan 26;13(3):. (PMID: 36766567)
Mol Biol Evol. 1993 May;10(3):512-26. (PMID: 8336541)
J Clin Microbiol. 2020 Mar 25;58(4):. (PMID: 31969423)
Viruses. 2023 Jan 27;15(2):. (PMID: 36851580)
Vaccine. 2003 Apr 1;21 Suppl 1:S36-40. (PMID: 12628812)
Transbound Emerg Dis. 2019 Jul;66(4):1701-1708. (PMID: 30985075)
J Infect Chemother. 2019 Oct;25(10):786-790. (PMID: 31105002)
Infect Drug Resist. 2021 Oct 19;14:4291-4299. (PMID: 34703255)
Adv Virol. 2019 Dec 24;2019:5323428. (PMID: 31933642)
Microbiol Immunol. 2011 Feb;55(2):100-7. (PMID: 21204948)
Vaccines (Basel). 2020 Feb 12;8(1):. (PMID: 32059489)
Viruses. 2021 Sep 19;13(9):. (PMID: 34578454)
Antiviral Res. 2019 Apr;164:23-51. (PMID: 30710567)
J Clin Virol. 2009 Jun;45(2):125-8. (PMID: 19409841)
Viruses. 2020 Oct 31;12(11):. (PMID: 33142676)
Eur J Clin Microbiol Infect Dis. 2015 Jul;34(7):1327-36. (PMID: 25796511)
Viruses. 2017 Nov 13;9(11):. (PMID: 29137162)
Viruses. 2022 Apr 11;14(4):. (PMID: 35458522)
J Virol. 2014 Dec;88(23):13845-57. (PMID: 25253341)
Eur J Neurol. 2017 Oct;24(10):1214-e61. (PMID: 28762591)
Microorganisms. 2021 May 29;9(6):. (PMID: 34072340)
Clin Vaccine Immunol. 2015 Jul;22(7):754-60. (PMID: 25924768)
Virology. 1991 Dec;185(2):891-5. (PMID: 1720591)
Nature. 1995 May 25;375(6529):291-8. (PMID: 7753193)
Med Microbiol Immunol. 2002 Mar;190(4):199-202. (PMID: 12005333)
معلومات مُعتمدة: 0564-2019-0001; 0837-2019-0007 and 0837-2019-0003 Ministry of Science and Higher Education of Russia
فهرسة مساهمة: Keywords: ELISA; TBEV; protein E; recombinant protein; serodiagnosis of orthoflaviviruses
تواريخ الأحداث: Date Created: 20231028 Latest Revision: 20231030
رمز التحديث: 20231030
مُعرف محوري في PubMed: PMC10606673
DOI: 10.3390/diagnostics13203277
PMID: 37892100
قاعدة البيانات: MEDLINE
الوصف
تدمد:2075-4418
DOI:10.3390/diagnostics13203277